Abu Aid Odai, Rohana Hanan, Azrad Maya, Peretz Avi
The Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel.
Clinical Microbiology Laboratory, Tzafon Medical Center, Poriya, Israel, affiliated with Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel.
Vaccine X. 2024 Oct 2;20:100569. doi: 10.1016/j.jvacx.2024.100569. eCollection 2024 Oct.
This study aimed to evaluate the attitudes of Israeli elderly population towards COVID-19 and influenza vaccines, and to assess factors contributing to these attitudes.
Four-hundred and one participants exhibiting symptoms consistent with COVID-19 or influenza were enrolled and filled out a questionnaire. A second questionnaire was filled out for hospitalized patients at discharge. Nasopharyngeal samples were collected and detected for COVID-19 and influenza presence by reverse transcription PCR. Participants were divided into 3 groups according to their attitude towards vaccine- Pro-vaccine, Anti-vaccine and Dependent group, which represented participants whose stance depended on disease infection rate.
Out of 401 participants, 11.2% (45/401) tested positive for COVID-19, 10.5% (42/401) were positive for Influenza A and one (0.2%) patient had Influenza B. The participants expressed varied beliefs about COVID-19 vaccine: 14.7% (59/401) agreed that it causes disease, 25.4% (102/401) doubted vaccine effectiveness and 22.9% (92/401) questioned vaccine safety. A higher percentage of individuals in Pro-Vaccine group (66.3%, 179/270) as compared to Anti-Vaccine (45.3%, 24/53) and to Dependent (60.3%, 47/78) groups had a COVID-19 history. Hospitalization history was significantly more common in Pro-Vaccine (11.1%, 30/270) and Dependent groups (16.7%, 13/78) than in Anti-Vaccine group (1.9%, 1/53).Influenza vaccine effectiveness was doubted by 19.7% (79/401), 18% (72/401) participants questioned safety, and 18.7% (75/401) agreed that the vaccine causes disease. The majority of both Dependent (54.2%, 13/24) and Pro-Vaccine (56.2%, 167/297) groups believed they received sufficient information about the vaccine, while only 25% (20/80) of the Anti-Vaccine group has similar impressions.
This analysis reveals a notable disinclination towards vaccination among some of the elderly, reflecting their deep and ingrained hesitancy. These findings emphasize the need for customized approaches to improve vaccine acceptance in this vulnerable group. Such strategies should consider the various motivations and influences shaping elderly perspectives, from individual health experiences to wider social and cultural factors.
本研究旨在评估以色列老年人群对新冠病毒疫苗和流感疫苗的态度,并评估影响这些态度的因素。
招募了401名出现与新冠病毒或流感相符症状的参与者,并让他们填写一份问卷。为出院的住院患者填写了第二份问卷。采集鼻咽样本,通过逆转录聚合酶链反应检测新冠病毒和流感病毒的存在情况。参与者根据其对疫苗的态度分为3组——支持疫苗组、反对疫苗组和依赖组,依赖组代表立场取决于疾病感染率的参与者。
在401名参与者中,45人(11.2%)新冠病毒检测呈阳性,42人(10.5%)甲型流感检测呈阳性,1名患者(0.2%)乙型流感检测呈阳性。参与者对新冠病毒疫苗表达了不同的看法:14.7%(59/401)的人认为疫苗会导致疾病,25.4%(102/401)的人怀疑疫苗有效性,22.9%(92/401)的人质疑疫苗安全性。与反对疫苗组(45.3%,24/53)和依赖组(60.3%,47/78)相比,支持疫苗组中曾感染新冠病毒的个体比例更高(66.3%,179/270)。支持疫苗组(11.1%,30/270)和依赖组(16.7%,13/78)的住院史明显比反对疫苗组(1.9%,1/53)更常见。19.7%(79/401)的人怀疑流感疫苗的有效性,18%(72/401)的参与者质疑其安全性,18.7%(75/401)的人认为疫苗会导致疾病。依赖组(54.2%,13/24)和支持疫苗组(56.2%,167/297)中的大多数人认为他们获得了关于疫苗的充分信息,而反对疫苗组中只有25%(20/80)的人有类似看法。
该分析揭示了一些老年人对疫苗接种明显的不情愿,反映出他们根深蒂固的犹豫态度。这些发现强调需要采取定制化方法来提高这一弱势群体对疫苗的接受度。此类策略应考虑影响老年人观点的各种动机和因素,从个人健康经历到更广泛的社会和文化因素。